Lipidio Pharmaceuticals Announces Close Of Series A Extension Financing, Bringing Total Round To Over $20M
Round Type
Series A
San DiegoBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Lipidio Pharmaceuticals Inc. (Lipidio), a biopharmaceutical company developing novel therapeutics for dermatological and metabolic diseases, announced today the close of an extension to its Series A financing, bringing the total amount raised to over $20M. In addition to current Series A investors, this extension was led with participation of several new investors, including Nancy Chang (former Founder and CEO of Tanox), John Maraganore (former Founding CEO of Alnylam) and Brent Saunders (former Chairman & CEO of Allergan), along with a selected group of world-renowned dermatologists. Previous investors in the Series A include other successful, serial entrepreneur biopharma executives, as well as two Institutional Investor firms, Alethea Capital and 3E Bioventures.
Quick answer
Lipidio Pharmaceuticals raised an undisclosed amount in a Series A round, dated November 10, 2022. Lipidio Pharmaceuticals is based in San Diego, California, United States.
- How much did Lipidio Pharmaceuticals raise?
- Lipidio Pharmaceuticals raised an undisclosed amount in a Series A round on November 10, 2022.
- What does Lipidio Pharmaceuticals do?
- At Lipidio, patients are at the center of all we do.
- Where is Lipidio Pharmaceuticals based and how big is it?
- Lipidio Pharmaceuticals is based in San Diego, California, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Lipidio Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Os Therapies raised $2M on November 16, 2022.
- MBX Biosciences, Inc. raised $47M on November 7, 2022.
- NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
Who to call at Lipidio Pharmaceuticals, and when
A new round usually means Lipidio Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lipidio Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lipidio Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lipidio Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lipidio Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansLipidio Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.